Prepare for your visit

Aleisha A Breen

Family · Saint Louis, MO · NPI 1659620102

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$1,224.65

in general payments reported to CMS, 2019-2025 · $292 in 2025

The $292 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).

Who reported paying

General payments only, top 6 by amount.

Acadia Pharmaceuticals INC $612.82
Neurocrine Biosciences, INC. $389.14
Glaxosmithkline, LLC. $121.17
Otsuka America Pharmaceutical, INC. $38.77
Mylan Specialty L.P. $29.80
Astrazeneca Pharmaceuticals LP $16.73

Drugs and devices associated with these payments

Nuplazid Ingrezza Arexvy Rexulti Yupelri

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Aleisha Breen listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10645075/aleisha-a-breen